Effectiveness and Efficiency of Two Models of Delivering Care to a Chronic Wound Population
Launched by QUEEN'S UNIVERSITY · Apr 10, 2008
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
The management of chronic wounds in the community is a pressing issue for home care authorities. The care of leg ulcers represents a considerable expense to the health care system. It has been estimated that the care of venous leg ulcers alone consumes 1% of the national health care budgets of the UK and France. A one-month prevalence study in the Ottawa Carleton region (pop. 750,000) revealed that 126 Community Care Access Centre Clients (CCAC - the regional health care authority) received over 1500 home nursing visits. During the course of a year this represents more than $600,000 in home...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- The client:
- • Admission to home care for care of a venous leg ulcer (below the knee to the foot)
- • Ability to travel to clinic
- • No major contraindication for clinic care (eg not being able to leave an ill spouse, refusal, etc.)
- Exclusion Criteria:
- • Treatment is contraindicated
- • The ulcer in question is not venous
- • The client cannot travel outside the home or travel is impeded
About Queen's University
Queen's University is a distinguished research institution located in Kingston, Ontario, Canada, known for its commitment to advancing knowledge and innovation in the health sciences. As a clinical trial sponsor, Queen's University fosters a collaborative environment that bridges academic research and clinical practice, aiming to enhance patient care and outcomes through rigorous scientific investigation. The university actively engages in a wide range of clinical studies, leveraging its expertise in diverse therapeutic areas to contribute to the development of new treatments and interventions. With a focus on ethical standards and regulatory compliance, Queen's University is dedicated to ensuring the integrity and reliability of its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ottawa, Ontario, Canada
Ottawa, Ontario, Canada
Patients applied
Trial Officials
Margaret B Harrison, RN, PhD
Principal Investigator
The Ottawa Hospital
Ian D Graham, PhD
Study Director
Clinical Epidemiology Unit, Ottawa Hospital-Civic Campus
Philip S Wells, PhD
Study Director
The Ottawa Hospital
Susan VanDeVelde, PhD
Study Director
Victorian Order of Nurses, Ottawa-Carleton Branch
Judith L Threinen, BSR, MHA
Study Director
Ottawa-Carleton Community Care Access Centre
Donna I Nicholson, Dip O&A
Study Director
Ottawa Carleton Community Care Access Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials